ACORDA THERAPEUTICS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3 USD | +3.45% |
|
-24.05% | -98.01% |
| 05-14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-10 | Liquidation Plan and Disclosure Statement Filed by Acorda Therapeutics, Inc. | CI |
Quotes 5-day view
End-of-day quote OTC Markets| 03/06/2024 | 04/06/2024 | 05/06/2024 | 06/06/2024 | 07/06/2024 | |
|---|---|---|---|---|---|
| Last | 0.35 $ | 0.28 $ | 0.3 $ | 0.29 $ | 0.3 $ |
| Volume | 76 313 | 129 128 | 51 780 | 24 794 | 408 |
| Change | -11.39% | -20.00% | +7.14% | -3.33% | +3.45% |
| Opening | 0.40 | 0.42 | 0.26 | 0.30 | 0.30 |
| High | 0.40 | 0.42 | 0.30 | 0.30 | 0.30 |
| Low | 0.35 | 0.28 | 0.25 | 0.27 | 0.30 |
Performance
| 1 day | +3.45% | ||
| 1 week | -24.05% | ||
| Current month | -24.05% | ||
| 1 month | -65.87% | ||
| 3 months | -97.80% | ||
| 6 months | -97.60% | ||
| Current year | -98.01% | ||
| 1 year | -97.42% | ||
| 3 years | -99.60% | ||
| 5 years | -99.97% | ||
| 10 years | -99.99% |
Volumes
marketsDaily volume
408
Avg. Volume 20 sessions
36 248
Avg. Volume 20 sessions USD
10 874.40
Record volume 1
6 521 070
Record volume 2
3 737 069
Record volume 3
2 676 708
Capital turnover ratio
0.03
Float rotation
0.03
Basic data
Capitalization (USD)
372 629
Net sales (USD)
117 633 000
Number of employees
102
Sales / Employee (USD)
1 153 265
Free-Float
99.33 %
Free-Float capitalization (USD)
370 224
Average Daily Capital Traded
2.92%
Highs and lows
1 week
0.25
0.42
1 month
0.250.97
Current year
0.2518.00
1 year
0.2518.21
3 years
0.25127.20
5 years
0.25969.60
10 years
0.255 454.00
Indicators
Moving average 5 days
0.30
Moving average 20 days
0.51
Moving average 50 days
1.22
Moving average 100 days
7.82
Price spread / (MMA5)
0.00%
Price spread / (MMA20)
+70.00%
Price spread / (MMA50)
+306.67%
Price spread / (MMA100)
+2,506.67%
STIM
RSI 9 days
30.65
RSI 14 days
29.56
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +3.45% | -24.05% | -98.01% | -97.42% | 373K | ||
| -0.51% | +6.08% | +18.72% | +48.79% | 125B | ||
| +0.22% | +2.33% | +14.19% | +35.79% | 108B | ||
| -1.44% | -0.26% | -4.93% | -8.29% | 24.21B | ||
| +0.51% | +4.08% | +3.23% | -3.95% | 22.78B | ||
| -0.54% | -0.36% | -10.44% | -28.25% | 17.96B | ||
| -0.45% | +0.66% | -41.74% | -33.01% | 16.43B | ||
| -0.79% | +5.05% | -13.31% | -30.32% | 16.37B | ||
| +1.43% | -0.32% | +2.44% | +44.82% | 13.58B | ||
| +5.01% | -5.04% | +27.89% | -3.58% | 11.66B | ||
| -0.56% | +3.27% | +83.45% | +187.41% | 9.17B | ||
| -2.13% | +13.90% | -24.26% | -33.18% | 8.31B | ||
| -0.96% | +1.53% | +8.91% | +51.74% | 7.87B | ||
| -2.12% | +1.00% | +13.01% | +38.48% | 7.72B | ||
| -0.60% | -1.77% | -5.61% | +22.76% | 7.29B | ||
| -1.15% | +14.81% | +37.58% | +46.46% | 6.47B | ||
| Average | -0.04% | +1.93% | +0.69% | +14.89% | ||
| Weighted average by Cap. | -0.18% | +3.41% | +10.00% | +28.05% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -98.01% | ||
| 2023 | -1.59% | ||
| 2022 | -67.92% | ||
| 2021 | -42.28% | ||
| 2020 | -66.17% | ||
| 2019 | -86.91% | ||
| 2018 | -27.37% | ||
| 2017 | +14.10% | ||
| 2016 | -56.05% | ||
| 2015 | +4.67% | ||
| 2014 | +39.97% | ||
| 2013 | +17.46% | ||
| 2012 | +4.28% | ||
| 2011 | -12.55% | ||
| 2010 | +8.17% | ||
| 2009 | +22.87% | ||
| 2008 | -6.60% | ||
| 2007 | +38.64% | ||
| 2006 | +135.71% |
- Stock Market
- Equities
- ACOR.Q Stock
- Quotes Acorda Therapeutics, Inc.
